Kite Pharma, Inc. Proceeds from Issuance Initial Public Offering
Kite Pharma, Inc. reported Proceeds from Issuance Initial Public Offering of -$23.59 million for the 12-month period ending 2014-12-31, per its 10-K filed 2015-03-26.
Discontinued › Cash Flow › Financing Activities
us-gaap:ProceedsFromIssuanceInitialPublicOffering · last filed 2015-08-10
- Kite Pharma, Inc. proceeds from issuance initial public offering for the quarter ending 2014-12-31 was -$11.09M.
- Kite Pharma, Inc. proceeds from issuance initial public offering for the quarter ending 2014-09-30 was -$1.55M.
- Kite Pharma, Inc. proceeds from issuance initial public offering for the quarter ending 2014-06-30 was -$10.81M.
- Kite Pharma, Inc. proceeds from issuance initial public offering for the quarter ending 2014-03-31 was -$133.00K.
- Kite Pharma, Inc. proceeds from issuance initial public offering for fiscal 2014 was -$23.59M.
| Period end | Proceeds from Issuance Initial Public Offering 1 month | Proceeds from Issuance Initial Public Offering 3 month | Proceeds from Issuance Initial Public Offering 6 month | Proceeds from Issuance Initial Public Offering 9 month | Proceeds from Issuance Initial Public Offering 12 month |
|---|---|---|---|---|---|
| 2014-12-31 | -$11.09M derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-26 | -$12.64M derived: sum of 2 quarters · filed 2015-03-26 | -$23.45M derived: sum of 3 quarters · filed 2015-08-10 | -$23.59M 10-K · filed 2015-03-26 | |
| 2014-09-30 | -$1.55M derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-14 | -$12.36M derived: sum of 2 quarters · filed 2015-08-10 | -$12.50M 10-Q · filed 2014-11-14 | ||
| 2014-06-30 | $134.10M 10-Q · filed 2014-08-14 | -$10.81M derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-10 | -$10.94M 10-Q · filed 2015-08-10 | ||
| 2014-03-31 | -$133.00K 10-Q · filed 2015-05-15 |